The objective of this study was to examine the association between personal use of hair dyes and the risk of leukemia. We conducted a systematic literature review of epidemiology studies reporting leukemia‐specific cancer risks among hair dye users, and estimated the meta‐relative risk (meta‐RR) and corresponding 95% confidence interval (95% CI) of leukemia, comparing hair dye users to nonusers. When data from all 20 studies that met the inclusion criteria were combined, ever use of hair dye was associated with a nonstatistically significant increased risk of leukemia, meta‐RR = 1.09 (95% CI: 0.97–1.22). When restricted to studies that adjusted for smoking, ever use of hair dye was not associated with leukemia, meta‐RR = 0.99 (95% CI: 0.76–1.29). A statistically significant increased risk of leukemia was associated with permanent hair dye use (meta‐RR = 1.19 [95% CI: 1.07–1.33]), dark hair dye use (meta‐RR = 1.29 [95% CI: 1.11–1.50]), hair dye use among males (meta‐RR = 1.42 [95% CI: 1.01–2.00]), hair dye use pre‐1980 (meta‐RR = 1.49 [95% CI: 1.21–1.83]), and hair dye use for ≥15 years (meta‐RR = 1.35 [95% CI: 1.13–1.62]). Overall, findings suggest that ever use of hair dye is not a significant risk factor for leukemia. Certain hair dye use characteristics were associated with a statistically significant increased risk, but further research is required to determine whether these associations truly reflect a risk of leukemia due to methodological limitations in the underlying studies.
Background: Recent concerns have been raised regarding heavy metal content in wine and its potential health implications. The goal of this study was to determine if lead (Pb) intake poses a health risk among adult consumers of wine. This was achieved by performing a literature review of studies reporting Pb concentration in United States and international wines, determining adult wine consumption rates in the United States using NHANES dietary survey data, utilizing the U.S. EPA's Adult Lead Methodology (ALM) model to estimate adult blood lead levels (BLLs) from wine consumption under various exposure scenarios, and comparing modeled BLLs to guidance values. Models were stratified by average exposure (mean wine Pb concentration) and high exposure (95 th percentile wine Pb concentration) scenarios. Results: Lead concentration data was abstracted from a total of 31 studies, including wine from 18 countries for a total of 472 wine samples. The mean Pb content of international red and white wines were 33.9 μg/L (n = 282) and 35.7 μg/L (n = 118), respectively, while the mean Pb content of domestic red wine was 4.4 μg/L (n = 61). All modelled BLLs were below the Center for Disease Control (CDC) BLL guidance value of 5 μg/dL. Assuming a mean baseline BLL, an individual was required to drink 10.4 glasses of wine per day (all wine types) under the average exposure scenario and 3.7 glasses of wine per day (all wine types) under the high exposure scenario in order to elevate their BLL to the guidance value of 5 μg/dL. When stratified by region, a minimum of approximately 24 glasses of wine from the United States per day was required to raise adult BLLs to the 5 μg/dL guidance value. Conclusions: Overall, findings suggest that Pb content in wine does not pose a health risk to adult wine consumers.
The MOSs for rinse-off products ranged from 5 to 63, whereas the MOSs for leave-on products ranged from 0.03 to 1.49. Overall, our results provide evidence that some leave-on products containing the maximum recommended safe concentration of Kathon CG may increase the risk of sensitization induction due to exposure to MCI/MI. In contrast, rinse-off products were not associated with a potential increased risk of skin sensitization induction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.